These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Outcome in chronic inflammatory demyelinating polyneuropathy from a Malaysian centre over sixteen years. Hiew FL; Ong JJ; Viswanathan S; Puvanarajah S J Clin Neurosci; 2018 Apr; 50():203-207. PubMed ID: 29398193 [TBL] [Abstract][Full Text] [Related]
29. Motor unit number index (MUNIX) in chronic inflammatory demyelinating polyneuropathy: A potential role in monitoring response to intravenous immunoglobulins. Lawley A; Seri S; Rajabally YA Clin Neurophysiol; 2019 Oct; 130(10):1743-1749. PubMed ID: 31400577 [TBL] [Abstract][Full Text] [Related]
30. Cranial nerve involvement in typical and atypical chronic inflammatory demyelinating polyneuropathies. Shibuya K; Tsuneyama A; Misawa S; Suichi T; Suzuki Y; Kojima Y; Nakamura K; Kano H; Prado M; Kuwabara S Eur J Neurol; 2020 Dec; 27(12):2658-2661. PubMed ID: 32876980 [TBL] [Abstract][Full Text] [Related]
31. Disability and health status in patients with chronic inflammatory demyelinating polyneuropathy. Westblad ME; Forsberg A; Press R Disabil Rehabil; 2009; 31(9):720-5. PubMed ID: 19034780 [TBL] [Abstract][Full Text] [Related]
32. Costs of illness in chronic inflammatory demyelinating polyneuropathy in Germany. Mengel D; Fraune L; Sommer N; Stettner M; Reese JP; Dams J; Glynn RJ; Balzer-Geldsetzer M; Dodel R; Tackenberg B Muscle Nerve; 2018 Nov; 58(5):681-687. PubMed ID: 30073683 [TBL] [Abstract][Full Text] [Related]
33. Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients. Alessandro L; Pastor Rueda JM; Wilken M; Querol L; Marrodán M; Acosta JN; Rivero A; Barroso F; Farez MF J Peripher Nerv Syst; 2018 Sep; 23(3):154-158. PubMed ID: 29603827 [TBL] [Abstract][Full Text] [Related]
34. Pathological spontaneous activity as a prognostic marker in chronic inflammatory demyelinating polyneuropathy. Grüter T; Motte J; Fisse AL; Bulut Y; Köse N; Athanasopoulos D; Otto S; Yoon MS; Schneider-Gold C; Gold R; Pitarokoili K Eur J Neurol; 2020 Dec; 27(12):2595-2603. PubMed ID: 32794258 [TBL] [Abstract][Full Text] [Related]
35. Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy. Chiò A; Cocito D; Bottacchi E; Buffa C; Leone M; Plano F; Mutani R; Calvo A; J Neurol Neurosurg Psychiatry; 2007 Dec; 78(12):1349-53. PubMed ID: 17494979 [TBL] [Abstract][Full Text] [Related]
36. Comparative value and determinants of suitability of outcome measures in treated chronic inflammatory demyelinating polyneuropathy. Rajabally YA; Ghasemi M Muscle Nerve; 2020 Feb; 61(2):182-186. PubMed ID: 31650551 [TBL] [Abstract][Full Text] [Related]